These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15029860)

  • 41. Secretin and autism: a two-part clinical investigation.
    Chez MG; Buchanan CP; Bagan BT; Hammer MS; McCarthy KS; Ovrutskaya I; Nowinski CV; Cohen ZS
    J Autism Dev Disord; 2000 Apr; 30(2):87-94. PubMed ID: 10832772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretin: real therapeutic potential (response).
    Rimland B
    J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):113; author reply 113-4. PubMed ID: 10697127
    [No Abstract]   [Full Text] [Related]  

  • 43. Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features.
    Alamy SS; Jarskog LF; Sheitman BB; Lieberman JA
    Schizophr Res; 2004 Feb; 66(2-3):183-6. PubMed ID: 15061252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naltrexone in infantile autism.
    Campbell M; Adams P; Small AM; Tesch LM; Curren EL
    Psychopharmacol Bull; 1988; 24(1):135-9. PubMed ID: 3387517
    [No Abstract]   [Full Text] [Related]  

  • 45. Lessons from secretin.
    Volkmar FR
    N Engl J Med; 1999 Dec; 341(24):1842-4. PubMed ID: 10588973
    [No Abstract]   [Full Text] [Related]  

  • 46. Treating autism pharmacologically: also tacrine might improve symptomatology in some cases.
    Niederhofer H
    J Child Neurol; 2007 Aug; 22(8):1054; author reply 1054-5. PubMed ID: 17761662
    [No Abstract]   [Full Text] [Related]  

  • 47. Compulsive masturbation in infantile autism treated by mirtazapine.
    Albertini G; Polito E; Sarà M; Di Gennaro G; Onorati P
    Pediatr Neurol; 2006 May; 34(5):417-8. PubMed ID: 16648008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medicine. Stalled trial for autism highlights dilemma of alternative treatments.
    Stokstad E
    Science; 2008 Jul; 321(5887):326. PubMed ID: 18635766
    [No Abstract]   [Full Text] [Related]  

  • 49. National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder.
    Gerhard T; Chavez B; Olfson M; Crystal S
    J Clin Psychopharmacol; 2009 Jun; 29(3):307-10. PubMed ID: 19440093
    [No Abstract]   [Full Text] [Related]  

  • 50. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L; Waldrop J
    Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sixty years of autism].
    van Berckelaer-Onnes IA
    Ned Tijdschr Geneeskd; 2004 May; 148(21):1024-30. PubMed ID: 15185436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. By any other name.
    Accardo PJ; Roseman B
    J Pediatr; 2000 May; 136(5):576-7. PubMed ID: 10802486
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous immunoglobulin treatment in autism.
    Plioplys AV
    J Autism Dev Disord; 2000 Feb; 30(1):73-4. PubMed ID: 10819125
    [No Abstract]   [Full Text] [Related]  

  • 55. Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.
    Anagnostou E; Esposito K; Soorya L; Chaplin W; Wasserman S; Hollander E
    J Clin Psychopharmacol; 2006 Aug; 26(4):444-6. PubMed ID: 16855475
    [No Abstract]   [Full Text] [Related]  

  • 56. Gold implants and increased expression of metallothionein-I/II as a novel hypothesized therapeutic approach for autism.
    Ghanizadeh A
    Toxicology; 2011 Apr; 283(1):63-4. PubMed ID: 21335051
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug discovery in autism: the need for a developmental context.
    Willemsen-Swinkels SH; Buitelaar JK
    Drug Discov Today; 2004 Jun; 9(11):473. PubMed ID: 15149620
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical management of autism.
    De Ocampo AC; Jacobs JM
    J S C Med Assoc; 2006 Oct; 102(8):274-6. PubMed ID: 17319242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.